This brand name is authorized in Romania
The drug REDITENS contains one active pharmaceutical ingredient (API):
|
1
Deferasirox
UNII V8G4MOF2V9 - DEFERASIROX
|
|
Deferasirox is an orally active chelator that is highly selective for iron (III). It is a tridentate ligand that binds iron with high affinity in a 2:1 ratio. Deferasirox promotes excretion of iron, primarily in the faeces. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V03AC03 | Deferasirox | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AC Iron chelating agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66802001, W66802002, W66802003, W66803001, W66803002, W66803003, W66804001, W66804002, W66804003 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
